Free Trial

United Therapeutics (UTHR) SEC Filings & 10K Form

$351.61
+4.73 (+1.36%)
(As of 08/21/2024 ET)

Recent United Therapeutics SEC Filings

DateFilerForm TypeView
08/20/2024
3:30 PM
EDGEMOND JAMES (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2024
3:30 PM
ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2024
3:30 PM
ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/09/2024
3:30 PM
ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2024
3:30 PM
BENKOWITZ MICHAEL (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2024
4:16 PM
BENKOWITZ MICHAEL (Reporting)
United Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/07/2024
4:17 PM
BENKOWITZ MICHAEL (Reporting)
United Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/07/2024
3:30 PM
ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/01/2024
9:54 AM
United Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
07/31/2024
3:30 PM
ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/31/2024
5:31 AM
United Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/31/2024
5:33 AM
United Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/29/2024
3:30 PM
ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/26/2024
3:30 PM
DWEK RAYMOND (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/26/2024
3:30 PM
KURZWEIL RAY (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/26/2024
3:30 PM
MALCOLM JAN (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/26/2024
3:30 PM
Mesa Nilda (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/26/2024
3:30 PM
PATUSKY CHRISTOPHER (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/26/2024
3:30 PM
MAXWELL LINDA (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/26/2024
3:30 PM
SULLIVAN LOUIS W (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/26/2024
3:30 PM
Thompson Tommy G (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/26/2024
3:30 PM
CAUSEY CHRISTOPHER (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/26/2024
3:30 PM
Giltner Richard (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/26/2024
3:30 PM
Olian Judy D. (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/25/2024
3:30 PM
ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/23/2024
3:30 PM
ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/19/2024
3:30 PM
ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2024
3:30 PM
ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/15/2024
3:30 PM
Giltner Richard (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/15/2024
3:30 PM
KURZWEIL RAY (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/15/2024
3:30 PM
Mesa Nilda (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/15/2024
3:30 PM
Olian Judy D. (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/15/2024
3:30 PM
PATUSKY CHRISTOPHER (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/15/2024
3:30 PM
ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/11/2024
3:30 PM
ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/09/2024
3:30 PM
ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/05/2024
3:30 PM
ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2024
3:30 PM
ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2024
3:30 PM
Thompson Tommy G (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2024
3:30 PM
ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2024
3:31 PM
MALCOLM JAN (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
This Crypto Is Set to Explode in August (Ad)

With the 2024 Bitcoin Halving, there's a potential HUGE bull run for altcoins. While everyone's chasing the latest DeFi craze or the next hot meme coin, the savviest investors are quietly positioning themselves for a different kind of explosion. This year's Bitcoin halving bull run is about to unleash a tidal wave in a completely undervalued sector of the crypto market.

Click here to review my research and see how this coin is at the center of a disruptive blockchain s
06/28/2024
3:30 PM
MALCOLM JAN (Reporting)
United Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/27/2024
6:30 AM
United Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/26/2024
3:08 PM
Thompson Tommy G (Reporting)
United Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/25/2024
3:36 PM
Mesa Nilda (Reporting)
United Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/24/2024
3:30 PM
MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2024
3:30 PM
ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
3:30 PM
CAUSEY CHRISTOPHER (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
3:30 PM
ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
3:37 PM
CAUSEY CHRISTOPHER (Reporting)
United Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/18/2024
3:30 PM
Olian Judy D. (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
3:30 PM
PATUSKY CHRISTOPHER (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
4:36 PM
PATUSKY CHRISTOPHER (Reporting)
United Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/17/2024
4:33 PM
Olian Judy D. (Reporting)
United Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/17/2024
3:30 PM
ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
3:30 PM
CAUSEY CHRISTOPHER (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
3:30 PM
ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
3:30 PM
ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
3:06 PM
CAUSEY CHRISTOPHER (Reporting)
United Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/10/2024
11:15 AM
United Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
06/07/2024
3:30 PM
ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
3:30 PM
ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2024
3:30 PM
ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2024
6:00 AM
United Therapeutics (Filer)
Form SD
Specialized Disclosure Report  
05/30/2024
3:30 PM
ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2024
3:30 PM
ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2024
3:30 PM
ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2024
3:30 PM
ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2024
3:30 PM
EDGEMOND JAMES (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2024
3:30 PM
CAUSEY CHRISTOPHER (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2024
3:10 PM
PATUSKY CHRISTOPHER (Reporting)
United Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/06/2024
3:30 PM
SULLIVAN LOUIS W (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2024
3:30 PM
Olian Judy D. (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2024
3:30 PM
CAUSEY CHRISTOPHER (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2024
3:04 PM
SULLIVAN LOUIS W (Reporting)
United Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/01/2024
5:32 AM
United Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/01/2024
5:34 AM
United Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/29/2024
6:00 AM
United Therapeutics (Filer)
Form DEF 14A
04/29/2024
6:02 AM
United Therapeutics (Filer)
Form DEFA14A
04/29/2024
6:07 AM
United Therapeutics (Filer)
Form ARS
04/25/2024
3:30 PM
ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/19/2024
3:30 PM
ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/17/2024
3:30 PM
ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/16/2024
3:30 PM
DWEK RAYMOND (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2024
3:30 PM
ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/11/2024
3:30 PM
ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/09/2024
3:30 PM
ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/09/2024
3:30 PM
DWEK RAYMOND (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/05/2024
3:30 PM
ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/04/2024
3:30 PM
MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/04/2024
3:07 PM
MAHON PAUL A (Reporting)
United Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
This Crypto Is Set to Explode in August (Ad)

With the 2024 Bitcoin Halving, there's a potential HUGE bull run for altcoins. While everyone's chasing the latest DeFi craze or the next hot meme coin, the savviest investors are quietly positioning themselves for a different kind of explosion. This year's Bitcoin halving bull run is about to unleash a tidal wave in a completely undervalued sector of the crypto market.

Click here to review my research and see how this coin is at the center of a disruptive blockchain s
04/03/2024
3:30 PM
ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/29/2024
3:30 PM
Mesa Nilda (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/29/2024
3:30 PM
United Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/29/2024
3:30 PM
ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/27/2024
3:30 PM
ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/25/2024
3:56 PM
United Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/25/2024
3:30 PM
ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/22/2024
3:30 PM
MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/21/2024
5:03 PM
MAHON PAUL A (Reporting)
United Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:UTHR) was last updated on 8/21/2024 by MarketBeat.com Staff

From Our Partners